Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;33(3):123-4.
doi: 10.5534/wjmh.2015.33.3.123. Epub 2015 Dec 23.

Evolution of Phosphodiesterase-5 Inhibitors

Du Geon Moon  1
Affiliations

Evolution of Phosphodiesterase-5 Inhibitors

Du Geon Moon. World J Mens Health. 2015 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.

Similar articles

See all similar articles

Cited by

References

    1. Ryu JK, Cho KS, Kim SJ, Oh KJ, Kam SC, Seo KK, et al. Korean Society for Sexual Medicine and Andrology (KSSMA) guideline on erectile dysfunction. World J Mens Health. 2013;31:83–102. - PMC - PubMed
    1. Ahn TY, Lee SW, Kim SW, Yang DY, Park NC, Min KS, et al. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil. Asian J Androl. 2007;9:760–770. - PubMed
    1. Kim BH, Lim HS, Chung JY, Kim JR, Lim KS, Sohn DR, et al. Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects. Br J Clin Pharmacol. 2008;65:848–854. - PMC - PubMed
    1. Park HJ, Moon KH, Lee SW, Lee WK, Kam SC, Lee JH, et al. Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature. World J Mens Health. 2014;32:18–27. - PMC - PubMed
    1. Zhao C, Kim SW, Yang DY, Kim JJ, Park NC, Lee SW, et al. Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial. BJU Int. 2012;110:1801–1806. - PubMed